John K. Clarke is an entrepreneur and businessperson who founded 8 companies, which include: Alnylam Pharmaceuticals, Inc., Cubist Pharmaceuticals LLC and Alkermes, Inc. and who has been at the head of 8 different companies. Currently, he holds the position of Chairman of aTyr Pharma, Inc. and Managing Partner at CHP Management, Inc. (which he founded in 2010). John K. Clarke is also on the board of Ivenix, Inc., Cureatr, Inc., Hands Together and Vividion Therapeutics, Inc.
Mr. Clarke previously was Independent Director at Alnylam Pharmaceuticals, Inc. (he founded the company in 2002), Chairman & President at Greater Philadelphia Venture Group, Chief Executive Officer of DNX Corp. (he founded the company), Chief Executive Officer of Arris Pharmaceuticals Corp. (he founded the company), Principal at General Electric Co., Chairman for Cubist Pharmaceuticals LLC (he founded the company in 1992), Chief Executive Officer for Alkermes, Inc. (he founded the company), Chief Executive Officer of Axys Pharmaceuticals, Inc., General Partner for DSV Partners IV LP and Director at Abide Therapeutics, Inc.
Mr. Clarke received an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree from Harvard University.